JPRN-UMIN000027257已完成未知
The assessment of synergistic effect of STFX and a-PDT to MRONJ - synergistic effect of STFX and a-PDT to MRONJ
agasaki University0 个研究点目标入组 12 人开始时间: 2017年5月8日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
Only 2 patients who underwent this protocol treatment, were followed up and the progress of both of them was good.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •hepatic or kidney disoeder allergy pregnant
研究者
相似试验
已完成
2 期
SFX-01 in the Treatment and Evaluation of Metastatic Breast CancerBreast NeoplasmNCT02970682Evgen Pharma60
已完成
不适用
Impact of Synergistic Sequential Treatment (SST)Improvement of Wrinkles/Elastosis as Well as General Skin ToneNCT01940445Lumenis Be Ltd.17
已完成
2 期
FOLFOX Followed by FOLFIRI or Reverse Sequence Treatment in Advanced Gastric Cancer (AGC)Gastric CancerNCT01138904Dong-A University Hospital80
已完成
2 期
A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRCColorectal NeoplasmsNCT02246049EPS Corporation69
尚未招募
2 期
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell CarcinomaOral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell CarcinomaRecurrent Oral and Oropharyngeal Squamous Cell CarcinomaNCT06728618Shanghai Zhongshan Hospital28